Tom Freyman - Clinical Immunology

Also on today's call will be Tom Freyman, Executive Vice President, Finance and Chief Financial Officer. So as we look ahead to the third quarter in our global nutritionals business, we expect high single-digit reported sales growth in both the U.S. and ...